Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer
ALTAK
Prevalence and Risk Factors for Persistent Tobacco or Alcohol Use Over the First Year of a First Lung or Head and Neck Cancer
2 other identifiers
observational
385
1 country
3
Brief Summary
This is an multicenter study for preventive and therapeutic strategies for patients with head and neck cancer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2012
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 19, 2012
CompletedFirst Posted
Study publicly available on registry
July 23, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedMarch 16, 2026
March 1, 2026
1.4 years
July 19, 2012
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
tobacco consumption
reported tobacco smoking
at 12 months
Secondary Outcomes (5)
tobacco smoking
at baseline, 3 and 6 months
alcohol drinking
at baseline, 3, 6 and 12 months
progression free survival
at 12 months
overall survival
at 12 months
sociodemographic, cancer-related, tobacco-related, alcohol-related, and psychiatric characteristics
at baseline
Study Arms (1)
head and neck or lung cancer
patient with a first head and neck cancer or first lung cancer
Interventions
* Socio-economic conditions and general features: educational level, professional status... * Assessment of current and past use of tobacco: current smoking status reported by the patient; in lifelong non-smokers: previous history of passive smoking reported by the patient; breath carbon monoxide level; in past smokers: age of first cigarette, total reported duration of active smoking, breath carbon monoxide level... * in current smokers: age of first tobacco use, total reported duration of active smoking; Fagerström Nicotine Dependence Test... * Assessment of the current and past uses of alcohol: previous-year assessment using the CAGE questionnaire and the AUDIT Test; average weekly alcohol consumption over the last 12 months... * Assessment of current use of cannabis using the Cannabis Abuse Screening Test * Psychiatric assessment using the MINI 5.0
Eligibility Criteria
patient with a first head and neck cancer or first lung cancer
You may qualify if:
- first head and neck or lung cancer
- first support
- age ≥ 18
- patient covered by health insurance
- signed informed consent
You may not qualify if:
- prior lung or head and neck cancer
- mesothelioma and oesophageal cancer
- unable to undergo trail medical follow up (geographical, social and psychological reasons)
- pregnant or nursing women
- patient under guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Oscar Lambretlead
- Centre Régional de Référence en Cancérologiecollaborator
- National Cancer Institute, Francecollaborator
Study Sites (3)
Centre Hospitalier Régional et Universitaire - Hopital CALMETTE
Lille, 59 037, France
Centre Hospitalier Régional et Universitaire - Hopital HURIEZ
Lille, 59 037, France
Oscar Lambret Center
Lille, 59020, France
Related Publications (1)
Vannimenus C, Bricout H, Le Rouzic O, Mouawad F, Chevalier D, Dansin E, Rotsaert L, Lefebvre G, Cottencin O, Porte H, Scherpereel A, El Fahsi A, Richard F, Rolland B; ALTAK Study Group. Compared characteristics of current vs. past smokers at the time of diagnosis of a first-time lung or head and neck cancer: a cross-sectional study. BMC Cancer. 2018 Apr 3;18(1):372. doi: 10.1186/s12885-018-4253-5.
PMID: 29614983DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Corinne VANNIMENUS, MD
Centre Hospitalier Régional et Universitaire LILLE
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2012
First Posted
July 23, 2012
Study Start
April 1, 2012
Primary Completion
September 1, 2013
Study Completion
September 1, 2014
Last Updated
March 16, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share